These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 18956295)

  • 1. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive.
    Wieckowska A; Feldstein AE
    Semin Liver Dis; 2008 Nov; 28(4):386-95. PubMed ID: 18956295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis.
    Adams LA; Feldstein AE
    J Dig Dis; 2011 Feb; 12(1):10-6. PubMed ID: 21091933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future.
    Wieckowska A; McCullough AJ; Feldstein AE
    Hepatology; 2007 Aug; 46(2):582-9. PubMed ID: 17661414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?
    Alkhouri N; Feldstein AE
    Metabolism; 2016 Aug; 65(8):1087-95. PubMed ID: 26972222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Noninvasive diagnosis of fatty liver disease].
    Qu Y; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):155-7. PubMed ID: 20196962
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease.
    Vizzutti F; Arena U; Nobili V; Tarquini R; Trappoliere M; Laffi G; Marra F; Pinzani M
    Ann Hepatol; 2009; 8(2):89-94. PubMed ID: 19502649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date.
    Albhaisi S; Sanyal AJ
    Pharmaceut Med; 2019 Dec; 33(6):451-463. PubMed ID: 31933238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease.
    Alkhouri N; Sedki E; Alisi A; Lopez R; Pinzani M; Feldstein AE; Nobili V
    Liver Int; 2013 Jan; 33(1):79-85. PubMed ID: 23146095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease.
    Arora A; Sharma P
    J Clin Exp Hepatol; 2012 Jun; 2(2):145-55. PubMed ID: 25755423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and diagnosis of NAFLD/NASH.
    Hashimoto E; Taniai M; Tokushige K
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():64-70. PubMed ID: 24251707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease.
    Castera L
    Semin Liver Dis; 2015 Aug; 35(3):291-303. PubMed ID: 26378645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive diagnosis of nonalcoholic fatty liver disease.
    Myers RP
    Ann Hepatol; 2009; 8 Suppl 1():S25-33. PubMed ID: 19381121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and natural history of non-alcoholic fatty liver disease.
    Fazel Y; Koenig AB; Sayiner M; Goodman ZD; Younossi ZM
    Metabolism; 2016 Aug; 65(8):1017-25. PubMed ID: 26997539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease.
    Yu AS; Keeffe EB
    Rev Gastroenterol Disord; 2002; 2(1):11-9. PubMed ID: 12122975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stepwise combination of simple noninvasive fibrosis scoring systems increases diagnostic accuracy in nonalcoholic fatty liver disease.
    Demir M; Lang S; Nierhoff D; Drebber U; Hardt A; Wedemeyer I; Schulte S; Quasdorff M; Goeser T; Töx U; Steffen HM
    J Clin Gastroenterol; 2013 Sep; 47(8):719-26. PubMed ID: 23442837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.
    Carter-Kent C; Zein NN; Feldstein AE
    Am J Gastroenterol; 2008 Apr; 103(4):1036-42. PubMed ID: 18177455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
    Tiniakos DG
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and management of obesity-related nonalcoholic fatty liver disease.
    Nugent C; Younossi ZM
    Nat Clin Pract Gastroenterol Hepatol; 2007 Aug; 4(8):432-41. PubMed ID: 17667992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee.
    Vajro P; Lenta S; Socha P; Dhawan A; McKiernan P; Baumann U; Durmaz O; Lacaille F; McLin V; Nobili V
    J Pediatr Gastroenterol Nutr; 2012 May; 54(5):700-13. PubMed ID: 22395188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.